In a recent interview with the Mesothelioma Applied Research Foundation or MARF, Dr. Harbut discusses his new research project which seeks to identify markers for mesothelioma using a non-invasive technique which samples organic compounds in the breath of test subjects. If successful, Dr. Harbut’s project will make it easier to screen individuals at risk for the mesothelioma through a breath test, thus more quickly diagnosing, and ultimately treating, patients.
Michael R. Harbut, MD, is a clinical professor of medicine at Michigan State University and the Medical Advisor to the International Heat and Frost Insulators and Allied Workers Union. He is co-author of the most recent diagnostic criteria for asbestos-related diseases for the American Thoracic Society. He is past chair of the Occupational and Environmental Medicine section of the American College of Chest Physicians.
Dr. Harbut’s research team has discovered the probable cause of intractable pleuritic pain in asbestos-exposed patients and his group has worked in the development of two mesothelioma tumor markers. He also conducted the world’s largest study of lung disease in Ironworkers.
You can listen to the podcast here: http://bit.ly/2GPQpbj
We will keep you informed about this study and other studies that relate to mesothelioma research.
